Pharmaron Beijing Co., Ltd. (SHE: 300759)

Market Cap	32.30B
Revenue (ttm)	11.50B
Net Income (ttm)	1.93B
Shares Out	1.78B
EPS (ttm)	1.09
PE Ratio	18.58
Forward PE	19.78
Dividend	0.20 (1.03%)
Ex-Dividend Date	Jun 27, 2024

Volume	17,186,866
Open	19.81
Previous Close	19.37
Day's Range	19.15 - 20.51
52-Week Range	17.70 - 37.00
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 20,295
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2023, Pharmaron Beijing's revenue was 11.54 billion, an increase of 12.39% compared to the previous year's 10.27 billion. Earnings were 1.60 billion, an increase of 16.48%.